Qilian International Holding Group Limited QLI

Annual report 2021
added 10-13-2022

Qilian International Holding Group Limited DPO Ratio 2011-2026 | QLI

Annual DPO Ratio Qilian International Holding Group Limited

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
39.1	18.8	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
39.1	18.8	28.9

DPO Ratio of other stocks in the Biotechnology industry

	Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
	AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
	I-Mab IMAB	2.24 K	-	-	$ 866 M	China
	Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
	Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
	ACADIA Pharmaceuticals ACAD	75.2	$ 22.82	2.1 %	$ 3.78 B	USA
	Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
	Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
	AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
	Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
	Arcutis Biotherapeutics ARQT	133	$ 23.4	-0.09 %	$ 2.98 B	USA
	Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
	Autolus Therapeutics plc AUTL	9.57	$ 1.68	2.44 %	$ 447 M	Britain
	Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
	Завод ДИОД DIOD	30.3	-	-	-	Russia
	Фармсинтез LIFE	306	-	-	-	Russia
	AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
	BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
	BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands